ALLURION TECHNOLOGIES, INC.
For the period ended Mar 31, 2026. Filed May 15, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 15, 2026
ALUR$0.67-5.6%Stored close · as of Mar 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Deficit
UNAUDITED CONDENSED CONSOLIDATED STATEM ENTS OF STOCKHOLDERS’ DEFICIT
(dollars in thousands, except share amounts)
| Common Sock | ||||||
|---|---|---|---|---|---|---|
| Additional · Accumulated Other · Accumulated · Stockholders’ | ||||||
| Shares | Amount | Paid-in Capital | Comprehensive Income (Loss) | Deficit | Deficit | |
| Balance as of January 1, 2025 | 2,710,607 | $3 | $152,596 | $(8,370) | $(222,207) | $(77,978) |
| Exercise of stock options | — | — | — | — | — | — |
| Issuance of common stock in connection with vesting of RSU awards | 3,505 | — | — | — | — | — |
| Issuance of common stock in connection with RTW Private Placement, net of issuance costs | 841,751 | — | 2,500 | — | — | 2,500 |
| Issuance of common stock in connection with January Public Offering, net of issuance costs | 1,240,000 | 1 | 1,262 | — | — | 1,263 |
| Issuance of common stock in connection with February Public Offering and Leavitt Private Placement, net of issuance costs | 1,167,686 | 1 | 588 | — | — | 589 |
| Stock-based compensation expense | — | — | 897 | — | — | 897 |
| Other comprehensive income | — | — | — | 4,440 | — | 4,440 |
| Net loss | — | — | — | — | (1,501) | (1,501) |
| Balance as of March 31, 2025 | 5,963,549 | $5 | $157,843 | $(3,930) | $(223,708) | $(69,790) |
| Balance as of January 1, 2026 | 12,279,181 | $6 | $168,627 | $5,140 | $(250,962) | $(77,189) |
| Issuance of common stock to consultants | 55,740 | — | 135 | — | — | 135 |
| Warrant Inducement | 2,659,565 | — | 3,611 | — | — | 3,611 |
| Stock-based compensation expense | — | — | 638 | — | — | 638 |
| Other comprehensive income | — | — | — | 990 | — | 990 |
| Net loss | — | — | — | — | (6,095) | (6,095) |
| Balance as of March 31, 2026 | 14,994,486 | $6 | $173,011 | $6,130 | $(257,057) | $(77,910) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.